{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:15:57Z","timestamp":1784128557720,"version":"3.55.0"},"reference-count":188,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.idnow.2023.104832","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T07:55:49Z","timestamp":1699602949000},"page":"104832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) \u2013 2023 SPILF"],"prefix":"10.1016","volume":"54","author":[{"given":"E.","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Loubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Poitrenaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schuldiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lesprit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0005","doi-asserted-by":"crossref","first-page":"e3280","DOI":"10.1002\/dmrr.3280","article-title":"Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)","volume":"36","author":"Lipsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0010","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K","article-title":"Increased mortality associated with diabetic foot ulcer","volume":"13","author":"Boyko","year":"1996","journal-title":"Diabetes Med"},{"key":"10.1016\/j.idnow.2023.104832_b0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.22.7.1029","article-title":"Lower extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers","volume":"22","author":"Adler","year":"1999","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.idnow.2023.104832_b0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/iwj.12932","article-title":"Diabetic foot infection: a critical complication","volume":"15","author":"Hurlow","year":"2018","journal-title":"Int Wound J"},{"issue":"2","key":"10.1016\/j.idnow.2023.104832_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10096-015-2544-1","article-title":"The microbiome of diabetic foot osteomyelitis","volume":"35","author":"Van Asten","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0030","doi-asserted-by":"crossref","first-page":"e3266","DOI":"10.1002\/dmrr.3266","article-title":"Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)","volume":"36","author":"Schaper","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.idnow.2023.104832_b0035","first-page":"571","article-title":"Recent advances in clinical practice and in basic research on diabetic neuropathy","volume":"63","author":"Yagihashi","year":"2011","journal-title":"Brain Nerve"},{"key":"10.1016\/j.idnow.2023.104832_b0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jss.2006.02.006","article-title":"Neurogenic factors in the impaired healing of diabetic foot ulcers","volume":"134","author":"Galkowska","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.idnow.2023.104832_b0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.mcna.2013.04.005","article-title":"Diagnosis and management of infection in the diabetic foot","volume":"97","author":"Peters","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.idnow.2023.104832_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdiacomp.2004.06.002","article-title":"Diabetic lower extremity infection: influence of physical, psychological, and social factors","volume":"19","author":"Peters","year":"2005","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.idnow.2023.104832_b0055","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/dc05-2425","article-title":"Risk factors for foot infections in individuals with diabetes","volume":"29","author":"Lavery","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/511036","article-title":"Validation of the Infectious Diseases Society of America's diabetic foot infection classification system","volume":"44","author":"Lavery","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0065","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ijcp.12440","article-title":"Contribution of infection and peripheral artery disease to severity of diabetic foot ulcers in Chinese patients","volume":"68","author":"Hao","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.idnow.2023.104832_b0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease","volume":"51","author":"Prompers","year":"2008","journal-title":"EURODIALE Study Diabetologia"},{"key":"10.1016\/j.idnow.2023.104832_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1534734615596891","article-title":"Can we stop antibiotic therapy when signs and symptoms have resolved in diabetic foot infection patients?","volume":"14","author":"Chu","year":"2015","journal-title":"Int J Low Extrem Wounds"},{"issue":"3","key":"10.1016\/j.idnow.2023.104832_b0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1464-5491.2001.00460.x","article-title":"The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb","volume":"18","author":"Raymakers","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0085","article-title":"From the diabetic foot ulcer and beyond: how do foot infections spread in patients with diabetes? Diabet","volume":"3","author":"Aragon-Sanchez","year":"2012","journal-title":"Foot Ankle"},{"key":"10.1016\/j.idnow.2023.104832_b0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1742-481X.2008.00457.x","article-title":"The pro-inflammatory environment in recalcitrant diabetic foot wounds","volume":"5","author":"Acosta","year":"2008","journal-title":"Int Wound J"},{"key":"10.1016\/j.idnow.2023.104832_b0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1742-481X.2011.00840.x","article-title":"Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment","volume":"8","author":"Berlanga-Acosta","year":"2011","journal-title":"Int Wound J"},{"key":"10.1016\/j.idnow.2023.104832_b0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0039-6109(16)46328-0","article-title":"Diabetic foot infections. Pathophysiology and treatment","volume":"74","author":"Bridges","year":"1994","journal-title":"Surg Clin North Am"},{"issue":"5","key":"10.1016\/j.idnow.2023.104832_b0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/153857440503900506","article-title":"Sepsis and the scalpel: anatomic compartments and the diabetic foot","volume":"39","author":"Maharaj","year":"2005","journal-title":"Vasc Endovascular Surg"},{"issue":"10","key":"10.1016\/j.idnow.2023.104832_b0110","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3390\/microorganisms8101580","article-title":"Biofilms in diabetic foot ulcers: significance and clinical relevance","volume":"8","author":"Pouget","year":"2020","journal-title":"Microorganisms"},{"issue":"8\u20139","key":"10.1016\/j.idnow.2023.104832_b0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.patbio.2007.07.003","article-title":"In vitro activity of tigecycline against strains isolated from diabetic foot ulcers","volume":"55","author":"Sotto","year":"2007","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.idnow.2023.104832_b0120","doi-asserted-by":"crossref","first-page":"e3326","DOI":"10.1371\/journal.pone.0003326","article-title":"Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP)","volume":"3","author":"Dowd","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.idnow.2023.104832_b0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/wound.2011.0333","article-title":"Clinically addressing biofilm in chronic wounds","volume":"1","author":"Attinger","year":"2012","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.idnow.2023.104832_b0130","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3389\/fmicb.2017.01791","article-title":"Microbiota of chronic diabetic wounds: ecology, impact, and potential for innovative treatment strategies","volume":"8","author":"Pereira","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.idnow.2023.104832_b0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jid.2016.08.009","article-title":"Temporal stability in chronic wound microbiota is associated with poor healing","volume":"137","author":"Loesche","year":"2017","journal-title":"J Investig Dermatol"},{"issue":"7","key":"10.1016\/j.idnow.2023.104832_b0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/wound.2014.0557","article-title":"Biofilms and wounds: an overview of the evidence","volume":"4","author":"Percival","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10.1016\/j.idnow.2023.104832_b0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4239\/wjd.v8.i4.135","article-title":"Osteomyelitis in diabetic foot: a comprehensive overview","volume":"8","author":"Giurato","year":"2017","journal-title":"World J Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0150","doi-asserted-by":"crossref","first-page":"e3281","DOI":"10.1002\/dmrr.3281","article-title":"Diagnosis of infection in the foot in diabetes: a systematic review","volume":"36","author":"Senneville","year":"2020","journal-title":"Diab Metab Res Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00365548.2013.765589","article-title":"The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds","volume":"45","author":"Mutluoglu","year":"2013","journal-title":"Scand J Inf Dis"},{"issue":"Suppl6","key":"10.1016\/j.idnow.2023.104832_b0160","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.12968\/jowc.2021.30.Sup6.S34","article-title":"Diabetic foot ulcer management in a multidisciplinary foot centre: one-year healing, amputation and mortality rate","volume":"30","author":"Van","year":"2021","journal-title":"J Wound Care"},{"key":"10.1016\/j.idnow.2023.104832_b0165","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1053\/j.jfas.2018.05.010","article-title":"Level of agreement with a multi-test approach to the diagnosis of diabetic foot osteomyelitis","volume":"57","author":"Meyr","year":"2018","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0170","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2337\/diacare.15.11.1527","article-title":"Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers","volume":"15","author":"Newman","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/iwj.12880","article-title":"The sausage toe as a sign of diabetic foot osteomyelitis","volume":"15","author":"Mutluoglu","year":"2018","journal-title":"Int Wound J"},{"key":"10.1016\/j.idnow.2023.104832_b0180","first-page":"100","article-title":"Diagnostic and therapeutic update on diabetic foot osteomyelitis","volume":"64","author":"L\u00e1zaro-Mart\u00ednez","year":"2017","journal-title":"Endoc Diab Nutri (English Ed.)"},{"key":"10.1016\/j.idnow.2023.104832_b0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cid\/ciw450","article-title":"Editorial commentary: probe-to-bone test for detecting diabetic foot osteomyelitis: rapid, safe, and accurate-but for which patients?","volume":"63","author":"Senneville","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diabet.2007.09.005","article-title":"Diabetic foot osteomyelitis","volume":"34","author":"Hartemann-Heurtier","year":"2008","journal-title":"Diab Metab"},{"key":"10.1016\/j.idnow.2023.104832_b0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1464-5491.2010.03150.x","article-title":"Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?","volume":"28","author":"Arag\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0200","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.diabres.2014.04.024","article-title":"Inter-observer reproducibility of diagnosis of diabetic foot osteomyelitis based on a combination of probe-to-bone test and simple radiography","volume":"105","author":"Alvaro-Afonso","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.idnow.2023.104832_b0205","first-page":"77","article-title":"Is Procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer?","volume":"42","author":"Zakariah","year":"2020","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.idnow.2023.104832_b0210","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/CORR.0000000000000718","article-title":"What are the optimal cutoff values for ESR and CRP to diagnose osteomyelitis in patients with diabetes-related foot infections?","volume":"477","author":"Lavery","year":"2019","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.idnow.2023.104832_b0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/iwj.12574","article-title":"Erythrocyte sedimentation rate and C-reactive protein to monitor treatment outcomes in diabetic foot osteomyelitis","volume":"14","author":"Van Asten","year":"2017","journal-title":"Int Wound J"},{"issue":"1","key":"10.1016\/j.idnow.2023.104832_b0220","first-page":"37","article-title":"Pro-calcitonin, erythrocyte sedimentation rate and C - reactive protein in predicting diabetic foot ulcer characteristics; a cross sectional study","volume":"7","author":"Hadavand","year":"2019","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.idnow.2023.104832_b0225","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00248-016-0867-9","article-title":"Bacterial contribution in chronicity of wounds","volume":"73","author":"Rahim","year":"2017","journal-title":"Microb Ecol"},{"key":"10.1016\/j.idnow.2023.104832_b0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/toxins8070209","article-title":"Staphylococcus aureus toxins and diabetic foot ulcers: role in pathogenesis and interest in diagnosis","volume":"8","author":"Dunyach-Remy","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.idnow.2023.104832_b0235","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/db12-0771","article-title":"The neuropathic diabetic foot ulcer microbiome is associated with clinical factors","volume":"62","author":"Gardner","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.idnow.2023.104832_b0240","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fcimb.2018.00282","article-title":"Exploring the microbiota of diabetic foot infections with culturomics","volume":"8","author":"Jneid","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10.1016\/j.idnow.2023.104832_b0245","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2337\/diacare.15.11.1531","article-title":"Prevalence of Corynebacteria in diabetic foot infections","volume":"15","author":"Bessman","year":"1992","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.idnow.2023.104832_b0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1469-0691.2010.03194.x","article-title":"Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis","volume":"17","author":"Lesens","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.idnow.2023.104832_b0255","doi-asserted-by":"crossref","first-page":"e3370","DOI":"10.1371\/journal.pone.0003370","article-title":"Virulent synergistic effect between Enterococcus faecalis and Escherichia coli assayed by using the Caenorhabditis elegans model","volume":"3","author":"Lavigne","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.idnow.2023.104832_b0260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.dsx.2015.04.007","article-title":"Diabetic foot ulcer-A review on pathophysiology, classification and microbial etiology","volume":"9","author":"Noor","year":"2015","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.idnow.2023.104832_b0265","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12916-020-01820-6","article-title":"The dynamic wound microbiome","volume":"18","author":"Liu","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.idnow.2023.104832_b0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41522-021-00202-x","article-title":"A multiomics approach to identify host-microbe alterations associated with infection severity in diabetic foot infections: a pilot study","volume":"7","author":"Radzieta","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.idnow.2023.104832_b0275","first-page":"72","article-title":"The microbiology of acute and chronic wounds","volume":"11","author":"Bowler","year":"1999","journal-title":"Wounds"},{"key":"10.1016\/j.idnow.2023.104832_b0280","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/clinids\/20.Supplement_2.S283","article-title":"Foot infections in diabetic patients: the role of anaerobes","volume":"20","author":"Gerding","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/0255-0857.188320","article-title":"Identification, antifungal resistance profile, in vitro biofilm formation and ultrastructural characteristics of Candida species isolated from diabetic foot patients in Northern India. Indian","volume":"34","author":"Kumar","year":"2016","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.idnow.2023.104832_b0290","doi-asserted-by":"crossref","first-page":"e01058","DOI":"10.1128\/mBio.01058-16","article-title":"Redefining the chronic-wound microbiome: Fungal communities are prevalent, dynamic, and associated with delayed healing","volume":"7","author":"Kalan","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.idnow.2023.104832_b0295","first-page":"30","article-title":"Outcome in diabetic foot ulcers with and without Staphylococcus aureus (MRSA)","volume":"20","author":"Game","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1464-5491.2004.1424-8.x","article-title":"MRSA and osteomyelitis of the foot in diabetes","volume":"21","author":"Game","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0305","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1464-5491.2004.01237.x","article-title":"Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact","volume":"21","author":"Hartemann-Heurtier","year":"2004","journal-title":"Diabet Med"},{"issue":"4 Pt 1","key":"10.1016\/j.idnow.2023.104832_b0310","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diabet.2008.02.005","article-title":"N\u00eemes University Hospital Working Group on the Diabetic Foot (GP30). Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers","volume":"34","author":"Richard","year":"2008","journal-title":"Diabetes Metab"},{"issue":"10","key":"10.1016\/j.idnow.2023.104832_b0315","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00125-010-1828-3","article-title":"Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers","volume":"53","author":"Sotto","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.idnow.2023.104832_b0320","unstructured":"Lavigne JP, Loiez C. Le pied diab\u00e9tique infect\u00e9. In : REMIC, Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, R\u00e9f\u00e9rentiel en Microbiologie M\u00e9dicale, Ed. Paris, 2018 31:295-300."},{"key":"10.1016\/j.idnow.2023.104832_b0325","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijsu.2010.11.011","article-title":"Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis","volume":"9","author":"Elamurugan","year":"2011","journal-title":"Int J Surg"},{"issue":"11","key":"10.1016\/j.idnow.2023.104832_b0330","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.2337\/dc20-3170","article-title":"Reliability and safety of bedside blind bone biopsy performed by a diabetologist for the diagnosis and treatment of diabetic foot osteomyelitis","volume":"44","author":"Feron","year":"2021","journal-title":"Diabetes Care"},{"issue":"35","key":"10.1016\/j.idnow.2023.104832_b0335","doi-asserted-by":"crossref","first-page":"e16877","DOI":"10.1097\/MD.0000000000016877","article-title":"Prevention, assessment, diagnosis and management of diabetic foot based on clinical practice guidelines: a systematic review","volume":"98","author":"P\u00e9rez-Panero","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.idnow.2023.104832_b0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1479164116666477","article-title":"Interdisciplinary treatment of diabetic foot wounds in the elderly: low risk of amputations and mortality and good chance of being mobile with good quality of life","volume":"14","author":"Hartmann","year":"2017","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.idnow.2023.104832_b0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1464-5491.2004.01363.x","article-title":"Creation of a multidisciplinary, evidence based, clinical guideline for the assessment, investigation and management of acute diabetes related foot complications","volume":"22","author":"Wraight","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0350","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2796.1994.tb01104.x","article-title":"Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation","volume":"235","author":"Apelqvist","year":"1994","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.idnow.2023.104832_b0355","doi-asserted-by":"crossref","first-page":"e3543","DOI":"10.7717\/peerj.3543","article-title":"A longitudinal study of the diabetic skin and wound microbiome","volume":"20","author":"Gardiner","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.idnow.2023.104832_b0360","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ebiom.2017.06.026","article-title":"Next generation DNA sequencing of tissues from infected diabetic foot ulcers","volume":"21","author":"Malone","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.idnow.2023.104832_b0365","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1099\/jmm.0.000907","article-title":"Examining diabetic heel ulcers through an ecological lens: microbial community dynamics associated with healing and infection","volume":"68","author":"Sloan","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.idnow.2023.104832_b0370","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.chom.2019.03.006","article-title":"Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy","volume":"25","author":"Kalan","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.idnow.2023.104832_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-020-0130-5","article-title":"Microbial predictors of healing and short-term effect of debridement on the microbiome of chronic wounds","volume":"6","author":"Verbanic","year":"2020","journal-title":"Npj Biofilms Microbiomes"},{"key":"10.1016\/j.idnow.2023.104832_b0380","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1099\/jmm.0.000907","article-title":"Examining diabetic heel ulcers through an ecological lens: microbial community dynamics associated with healing and infection","volume":"68","author":"Radzieta","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.idnow.2023.104832_b0385","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/j.jfas.2018.03.016","article-title":"Concordance between bone pathology and bone culture for the diagnosis of osteomyelitis in the presence of charcot neuro-osteoarthropathy","volume":"57","author":"Elmersafi","year":"2018","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0390","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.jfas.2011.08.005","article-title":"Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis","volume":"50","author":"Meyr","year":"2011","journal-title":"J Foot Ankle Surg"},{"issue":"2","key":"10.1016\/j.idnow.2023.104832_b0395","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/dme.13824","article-title":"Cortical disruption is the most reliable and accurate plain radiographic sign in the diagnosis of diabetic foot osteomyelitis","volume":"36","author":"\u00c1lvaro-Afonso","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0400","unstructured":"Tran K, Mierzwinski-Urban M. Serial X-Ray Radiography for the Diagnosis of Osteomyelitis: A Review of Diagnostic Accuracy, Clinical Utility, Cost- Effectiveness, and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. 2020 Mar 13. PMID: 33074603."},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0405","doi-asserted-by":"crossref","first-page":"e3250","DOI":"10.1002\/dmrr.3250","article-title":"Diagnosing diabetic foot osteomyelitis","volume":"36","author":"Senneville","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0410","doi-asserted-by":"crossref","first-page":"e3281","DOI":"10.1002\/dmrr.3281","article-title":"Diagnosis of infection in the foot in diabetes: a systematic review","volume":"36","author":"Senneville","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.idnow.2023.104832_b0415","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1573399816999200729124134","article-title":"X-Ray versus magnetic resonance imaging in diabetic foot osteomyelitis: a clinical comparison","volume":"17","author":"Gariani","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"10.1016\/j.idnow.2023.104832_b0420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00256-018-3045-y","article-title":"Added value of MRI to X-ray in guiding the extent of surgical resection in diabetic forefoot osteomyelitis: a review of pathologically proven, surgically treated cases","volume":"48","author":"Cohen","year":"2019","journal-title":"Skeletal Radiol"},{"issue":"6","key":"10.1016\/j.idnow.2023.104832_b0425","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/jcm9061779","article-title":"Diabetic foot infections: the diagnostic challenges","volume":"9","author":"Lauri","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.idnow.2023.104832_b0430","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3390\/jcm9061645","article-title":"Comparison of white blood cell scintigraphy, FDG PET\/CT and MRI in suspected diabetic foot infection: results of a large retrospective multicenter study","volume":"9","author":"Lauri","year":"2020","journal-title":"J Clin Med"},{"issue":"16","key":"10.1016\/j.idnow.2023.104832_b0435","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcot.2020.12.033","article-title":"Update on functional imaging in the evaluation of diabetic foot infection","volume":"11","author":"Iyengar","year":"2021","journal-title":"J Clin Orthop Trauma"},{"issue":"4","key":"10.1016\/j.idnow.2023.104832_b0440","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.foot.2013.07.002","article-title":"Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis","volume":"23","author":"Treglia","year":"2013","journal-title":"Foot (Edinb)"},{"issue":"12","key":"10.1016\/j.idnow.2023.104832_b0445","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2174\/1381612824666180227095439","article-title":"Diabetic Foot Infection: The Role of PET\/CT Imaging","volume":"24","author":"Arnon-Sheleg","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.idnow.2023.104832_b0450","first-page":"CD011038","article-title":"Topical antimicrobial agents for treating foot ulcers in people with diabetes","volume":"6","author":"Dumville","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0455","doi-asserted-by":"crossref","DOI":"10.1177\/2050312118773950","article-title":"A randomized controlled trial of the safety and efficacy of a topical gentamicin-collagen sponge in diabetic patients with a mild foot ulcer infection","volume":"6","author":"U\u00e7kay","year":"2018","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.idnow.2023.104832_b0460","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12879-018-3253-z","article-title":"A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection","volume":"18","author":"U\u00e7kay","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.idnow.2023.104832_b0465","article-title":"Systemic antibiotics for treating diabetic foot infections","volume":"2015","author":"Selva Olid","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0470","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/QCO.0000000000000530","article-title":"Principles and practice of antibiotic stewardship in the management of diabetic foot infections","volume":"32","author":"Uckay","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0475","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dmrr.2248","article-title":"Expert opinion on the management of infections in the diabetic foot","volume":"28","author":"Lipsky","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0480","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/dmrr.2247","article-title":"A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot","volume":"28","author":"Peters","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0485","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/iwj.12926","article-title":"Role of anaerobes in polymicrobial communities and biofilms complicating diabetic foot ulcers","volume":"15","author":"Percival","year":"2018","journal-title":"Int Wound J"},{"key":"10.1016\/j.idnow.2023.104832_b0490","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.45.2.525-531.2001","article-title":"Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections","volume":"45","author":"Siami","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idnow.2023.104832_b0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239236","article-title":"Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a meta-analysis","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.idnow.2023.104832_b0500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.dsx.2018.05.007","article-title":"Short-term predictors of amputation in patients with diabetic foot ulcers","volume":"12","author":"Ferreira","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.idnow.2023.104832_b0505","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1056-8727(99)00065-3","article-title":"Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis","volume":"13","author":"Eneroth","year":"1999","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.idnow.2023.104832_b0510","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinte.159.8.851","article-title":"Outcome of diabetic foot infections treated conservatively. a retrospective cohort study with long-term follow-up","volume":"159","author":"Pittet","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idnow.2023.104832_b0515","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3904\/kjim.2016.165","article-title":"Depth and combined infection is important predictor of lower extremity amputations in hospitalized diabetic foot ulcer patients","volume":"33","author":"Jeong","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.idnow.2023.104832_b0520","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcot.2021.04.012","article-title":"Surgical management of the acute severely infected diabetic foot-The \u2018infected diabetic foot attack\u2019. An instructional review","volume":"18","author":"Ahluwalia","year":"2021","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.idnow.2023.104832_b0525","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.dsx.2018.12.021","article-title":"Operative versus non-operative treatment in diabetic dry toe gangrene","volume":"13","author":"Al","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.idnow.2023.104832_b0530","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcot.2021.02.019","article-title":"Surgical strategies for prevention of amputation of the diabetic foot","volume":"17","author":"Frykberg","year":"2021","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.idnow.2023.104832_b0535","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/clinids\/23.2.286","article-title":"Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?","volume":"23","author":"Tan","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0540","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.surge.2020.01.007","article-title":"An evidence based narrative review on treatment of diabetic foot osteomyelitis","volume":"18","author":"Aicale","year":"2020","journal-title":"Surgeon"},{"key":"10.1016\/j.idnow.2023.104832_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.foot.2019.08.008","article-title":"Transmetatarsal amputation: a 12 year retrospective case review of outcomes","volume":"42","author":"Joyce","year":"2020","journal-title":"Foot (Edinb)"},{"key":"10.1016\/j.idnow.2023.104832_b0550","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jvs.2019.10.083","article-title":"Short-term contemporary outcomes for staged versus primary lower limb amputation in diabetic foot disease","volume":"72","author":"Cheun","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0555","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcot.2020.12.014","article-title":"Conservative surgery for chronic diabetic foot osteomyelitis: Procedures and recommendations","volume":"16","author":"Lazaro-Mart\u00ednez","year":"2021","journal-title":"J Clin Orthop Trauma"},{"issue":"4","key":"10.1016\/j.idnow.2023.104832_b0560","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/medicina57040339","article-title":"Treating diabetic foot osteomyelitis: a practical state-of-the-art update","volume":"57","author":"Lipsky","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.idnow.2023.104832_b0565","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jvs.2019.08.244","article-title":"A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers","volume":"71","author":"Musuuza","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0570","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.jfas.2019.09.019","article-title":"Transmetatarsal and minor amputation versus major leg amputation: 30-day readmissions, reamputations, and complications","volume":"59","author":"Jupiter","year":"2020","journal-title":"J Foot Ankle Surg"},{"issue":"5","key":"10.1016\/j.idnow.2023.104832_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107886","article-title":"Minor vs. major leg amputation in adults with diabetes: six-month readmissions, reamputations, and complications","volume":"35","author":"Ratliff","year":"2021","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.idnow.2023.104832_b0580","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab184","article-title":"Deferring amputation in diabetic foot osteomyelitis: doing more harm than good?","volume":"8","author":"Zhou","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idnow.2023.104832_b0585","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/jcm10061237","article-title":"Medical versus surgical treatment for the management of diabetic foot osteomyelitis: a systematic review","volume":"10","author":"Tard\u00e1guila-Garc\u00eda","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.idnow.2023.104832_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.foot.2021.101784","article-title":"The level of evidence of the publications on conservative surgery for the treatment of diabetic forefoot ulcers: a scoping review","volume":"47","author":"Yammine","year":"2021","journal-title":"Foot (Edinb)"},{"key":"10.1016\/j.idnow.2023.104832_b0595","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/dc13-2510","article-title":"Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question?","volume":"37","author":"Lipsky","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0600","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00125-008-1131-8","article-title":"Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement","volume":"51","author":"Arag\u00f3n-S\u00e1nchez","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.idnow.2023.104832_b0605","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/DMSO.S181198","article-title":"Optimal management of diabetic foot osteomyelitis: challenges and solutions","volume":"12","author":"Lazaro-Martinez","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.idnow.2023.104832_b0610","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc13-1526","article-title":"Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial","volume":"37","author":"Lazaro-Mart\u0131nez","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijid.2015.09.023","article-title":"Diabetic foot infections: what have we learned in the last 30 years?","volume":"40","author":"U\u00e7kay","year":"2015","journal-title":"Intern J Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0620","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00125-008-0976-1","article-title":"Primarily non-surgical management of osteomyelitis of the foot in diabetes","volume":"51","author":"Game","year":"2008","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.idnow.2023.104832_b0625","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/1534734614559931","article-title":"Staphylococcus aureus\u2013Related diabetic osteomyelitis: medical or surgical management? A french and spanish retrospective cohort","volume":"14","author":"Lesens","year":"2015","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.idnow.2023.104832_b0630","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.otsr.2012.09.012","article-title":"Major amputation of lower extremity: Prognostic value of positive bone biopsy cultures","volume":"99","author":"Vaznaisiene","year":"2013","journal-title":"Orthop Traumatol Surg Res"},{"issue":"15","key":"10.1016\/j.idnow.2023.104832_b0635","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12879-015-0993-x","article-title":"Section\u2019s osseous slice biopsy during major amputation of lower extremity: preliminary results of prospective cohort study","volume":"30","author":"Vaznaisiene","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0640","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.jfas.2010.12.009","article-title":"The effect of residual osteomyelitis at the resection margin in patients with surgically treated diabetic foot infection","volume":"50","author":"Kowalski","year":"2011","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0645","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2106\/JBJS.17.01152","article-title":"Culture of bone biopsy specimens overestimates rate of residual osteomyelitis after toe or forefoot amputation","volume":"100","author":"Mijuskovic","year":"2018","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0650","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1938640018770285","article-title":"Prospective analysis of surgical bone margins after partial foot amputation in diabetic patients admitted with moderate to severe foot infections","volume":"12","author":"Schmidt","year":"2019","journal-title":"Foot Ankle Spec"},{"issue":"4","key":"10.1016\/j.idnow.2023.104832_b0655","doi-asserted-by":"crossref","first-page":"e14440","DOI":"10.1111\/dme.14440","article-title":"Microbiological evaluation of resection margins of the infected diabetic foot ulcer","volume":"38","author":"Macauley","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.idnow.2023.104832_b0660","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7150\/jbji.45338","article-title":"Surgical techniques for bone biopsy in diabetic foot infection, and association between results and treatment duration","volume":"5","author":"Senneville","year":"2020","journal-title":"J Bone Joint Infect"},{"key":"10.1016\/j.idnow.2023.104832_b0665","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0670","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/dom.13507","article-title":"Remission in diabetic foot infections: duration of antibiotic therapy and other possible associated factors","volume":"21","author":"Gariani","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.idnow.2023.104832_b0675","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.idnow.2020.12.001","article-title":"Anti-infectious treatment duration: the SPILF and GPIP French guidelines and recommendations","volume":"51","author":"Gauzit","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.idnow.2023.104832_b0680","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.medmal.2020.04.015","article-title":"Short duration of post-amputation antibiotic therapy in diabetic foot patients with total resection of osteomyelitis","volume":"50","author":"Julien","year":"2020","journal-title":"Med Mal Infect"},{"issue":"2","key":"10.1016\/j.idnow.2023.104832_b0685","doi-asserted-by":"crossref","first-page":"e00059","DOI":"10.1002\/edm2.59","article-title":"Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort","volume":"2","author":"Rossel","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.idnow.2023.104832_b0690","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc13-1526","article-title":"Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: A randomized comparative trial","volume":"37","author":"Lazaro-Mart\u0131nez","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0695","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1534734616661058","article-title":"Treatment failure and leg amputation among patients with foot osteomyelitis","volume":"15","author":"Barshes","year":"2016","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.idnow.2023.104832_b0700","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1464-5491.2006.01785.x","article-title":"Systematic review of antimicrobial treatments for diabetic foot ulcers","volume":"23","author":"Nelson","year":"2006","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0705","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1002\/dmrr.836","article-title":"Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment","volume":"24","author":"Berendt","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0710","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/dmrr.2706","article-title":"A systematic review of interventions in the management of infection in the diabetic foot","volume":"32","author":"Peters","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.idnow.2023.104832_b0715","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14787210.2018.1417037","article-title":"Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches","volume":"16","author":"Arag\u00f3n-S\u00e1nchez","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0720","doi-asserted-by":"crossref","first-page":"e3282","DOI":"10.1002\/dmrr.3282","article-title":"Interventions in the management of infection in the foot in diabetes: a systematic review","volume":"36","author":"Peters","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.idnow.2023.104832_b0725","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.diagmicrobio.2013.12.007","article-title":"Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis","volume":"78","author":"Lauf","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idnow.2023.104832_b0730","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0735","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/dc07-1744","article-title":"Outcome of diabetic foot osteomyelitis treated nonsurgically. A retrospective cohort study","volume":"31","author":"Senneville","year":"2008","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.idnow.2023.104832_b0740","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.2337\/dc17-1471","article-title":"Two-Step sequential approach for concomitant skin and soft tissue infection and osteomyelitis complicating the diabetic foot","volume":"40","author":"Berthol","year":"2017","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.idnow.2023.104832_b0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2023.104832_b0750","unstructured":"HAS. Recommandations de bonnes pratiques. Antibioth\u00e9rapie des infections \u00e0 ent\u00e9robact\u00e9ries et \u00e0 Pseudomonas aeruginosa chez l\u2019adulte : place des carbap\u00e9n\u00e8mes et de leurs alternatives M\u00e9thode Recommandations pour la pratique clinique. Mai 2019. http:\/\/www.has-sante.frhttp:\/\/www.has-sante.fr. Last consulted March 6; 2023."},{"issue":"7","key":"10.1016\/j.idnow.2023.104832_b0755","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fmed.2020.00131","article-title":"A severe diabetic foot ulcer with intermediate cuneiform displacement and multidrug-resistant pseudomonas aeruginosa infection: a rare case report","volume":"21","author":"Chai","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"24","key":"10.1016\/j.idnow.2023.104832_b0760","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/ajhp\/zxab294","article-title":"Intravenous fosfomycin as salvage therapy for osteomyelitis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"78","author":"Wong","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.idnow.2023.104832_b0765","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2023.104832_b0770","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.2147\/DDDT.S313756","article-title":"Real-World use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: a careful appraisal beyond approved indications focusing on unmet clinical needs","volume":"15","author":"Gatti","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.idnow.2023.104832_b0775","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy331","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0780","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/AAC.00286-06","article-title":"In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections","volume":"50","author":"Goldstein","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2023.104832_b0785","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/jac\/dkab117","article-title":"In vitro activity of dalbavancin against Gram-positive bacteria isolated from diabetic foot osteomyelitis","volume":"76","author":"Pantel","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2023.104832_b0790","doi-asserted-by":"crossref","unstructured":"Navarro-Jim\u00e9nez G, Fuentes-Santos C, Moreno-N\u00fa\u00f1ez L, Alfayate-Garc\u00eda J, Campelo-Gutierrez C, Sanz-M\u00e1rquez S, et al. Experience in the use of dalbavancin in diabetic foot infection. Enferm Infecc Microbiol Clin (Engl Ed). 2022:S2529-993X.","DOI":"10.1016\/j.eimce.2022.03.001"},{"key":"10.1016\/j.idnow.2023.104832_b0795","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1310422","article-title":"Single-dose oritavancin in the treatment of acute bacterial skin infections","volume":"370","author":"Corey","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2023.104832_b0800","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/ciu778","article-title":"Single-dose oritavancin versus 7\u201310 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl1","key":"10.1016\/j.idnow.2023.104832_b0805","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40801-020-00194-8","article-title":"Real-World Use of Oritavancin for the Treatment of Osteomyelitis","volume":"7","author":"Scoble","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.idnow.2023.104832_b0810","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40801-020-00195-7","article-title":"Treatment of acute osteomyelitis with once-weekly oritavancin: a two-year, multicenter, retrospective study","author":"Van Hise","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.idnow.2023.104832_b0815","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.idnow.2023.104832_b0820","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0825","first-page":"e01880","article-title":"Comparative assessment of tedizolid pharmacokinetics and tissue penetration between diabetic patients with wound infections and healthy volunteers via in vivo microdialysis","volume":"62","author":"Stainton","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2023.104832_b0830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/antibiotics10010004","article-title":"Tolerance of prolonged oral tedizolid for prosthetic joint infections: results of a multicentre prospective study","volume":"10","author":"Senneville","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.idnow.2023.104832_b0835","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/antibiotics10010053","article-title":"Long-Term use of tedizolid in osteoarticular infections: benefits among oxazolidinone drugs","volume":"10","author":"Benavent","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.idnow.2023.104832_b0840","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1093\/jac\/dkx329","article-title":"Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study","volume":"72","author":"Pullman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2023.104832_b0845","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/cid\/ciy165","article-title":"A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study","volume":"67","author":"O\u2019Riordan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0850","unstructured":"Nicola F, Azula N, Santoni G, Smayevsky J. Actividad in vitro de delafloxacina frente a microorganismos aislados de infecciones osteoarticulares y de piel y partes blandas en Buenos Aires, Argentina [In vitro activity of delafloxacin against bacterial isolates from osteoarticular and skin infections in Buenos Aires, Argentina]. Rev Argent Microbiol. 2021:S0325-7541(21)00047-X."},{"key":"10.1016\/j.idnow.2023.104832_b0855","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diagmicrobio.2013.03.019","article-title":"Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds","volume":"76","author":"Goldstein","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0860","doi-asserted-by":"crossref","unstructured":"Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T, et al. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010;65 Suppl4:iv41-51.1.","DOI":"10.1086\/655827"},{"issue":"Suppl4","key":"10.1016\/j.idnow.2023.104832_b0865","first-page":"iv53","article-title":"CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","volume":"65","author":"Wilcox","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2023.104832_b0870","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/dmrr.2624","article-title":"Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience","volume":"31","author":"Lipsky","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"10.1016\/j.idnow.2023.104832_b0875","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/AAC.00722-06","article-title":"In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections","volume":"50","author":"Goldstein","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2023.104832_b0880","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SLA.0000000000005205","article-title":"Moderate to severe soft tissue diabetic foot infections. a randomized, controlled, pilot trial of post-debridement antibiotic treatment for 10 versus 20 days","volume":"276","author":"Pham","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.idnow.2023.104832_b0885","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/medicina57040339","article-title":"Treating diabetic foot osteomyelitis: a practical state-of-the-art update","volume":"57","author":"Lipsky","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.idnow.2023.104832_b0890","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2337\/dc14-1514","article-title":"Six-week versus twelve-week antibiotictherapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study","volume":"38","author":"Tone","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0895","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1093\/cid\/ciaa1758","article-title":"Three weeks versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, noninferiority","volume":"73","author":"Gariani","year":"2021","journal-title":"Pilot Trial Clin Infect Dis"},{"key":"10.1016\/j.idnow.2023.104832_b0900","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13063-019-4006-z","article-title":"Optimization of the antibiotic management of diabetic foot infections: protocol for two randomized controlled trials","volume":"21","author":"Waibel","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.idnow.2023.104832_b0905","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/dom.14222","article-title":"Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot?","volume":"2","author":"Pham","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.idnow.2023.104832_b0910","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/iwj.12433","article-title":"Hybrid imaging with 99mTc-WBC SPECT\/CT to monitor the effect of therapy in diabetic foot osteomyelitis","volume":"13","author":"Lazaga","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.idnow.2023.104832_b0915","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00125-017-4417-x","article-title":"Application of white blood cell SPECT\/CT to predict remission after a 6 or 12 week course of antibiotic treatment for diabetic foot osteomyelitis","volume":"60","author":"Vouillarmet","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.idnow.2023.104832_b0920","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MNM.0000000000001390","article-title":"99mTc-white blood cell SPECT\/CT to assess diabetic foot osteomyelitis remission: contribution of semi-quantitative scoring system","volume":"42","author":"Vouillarmet","year":"2021","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.idnow.2023.104832_b0925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dc06-1600","article-title":"Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool","volume":"30","author":"Lavery","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.idnow.2023.104832_b0930","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.idnow.2023.104832_b0935","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.foot.2017.12.004","article-title":"Risk factors for diabetic foot ulcer recurrence: a prospective 2-year follow-up study in Egypt","volume":"35","author":"Khalifa","year":"2018","journal-title":"Foot (Edinb)"},{"key":"10.1016\/j.idnow.2023.104832_b0940","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192300194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192300194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:34:38Z","timestamp":1763019278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266699192300194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":188,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S266699192300194X"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2023.104832","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) \u2013 2023 SPILF","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2023.104832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104832"}}